Woodcock to CDER as Galson named acting surgeon general

Share this article:
Dr. Janet Woodcock will assume the role of acting director of the Center for Drug Evaluation and Research (CDER) as the center's previous director, Dr. Steven Galson, becomes acting surgeon general.

Woodcock will retain her position as deputy commissioner and permanent chief medical officer, and will work with FDA Commissioner Andrew von Eschenbach to launch a national search for a permanent director of the center, the FDA said.

Of Galson, von Eschenbach said: "Because of his accomplishments, Americans have access to safer and more effective medical products than ever before. I know Steven will excel as our nation's chief health educator and Americans will continue to benefit from his dedication to public service."
Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union